CryoLife Continues to Add Expertise to Company's Board of Directors
Mr. Schwartz retired from Prudential Securities in 1996 after 33
years of service. While at Prudential Securities he held various
positions including co-head of the Investment Banking Division,
Managing Director of the firm's International Division and Managing
Director of the Health Care Group. Mr. Schwartz is a graduate of
Columbia University and has served on the Board of Directors of
several public and privately held companies.
Steven G. Anderson, President and Chief Executive Officer of
CryoLife, said, "Recently, we have been very fortunate to add
experienced members from diverse business backgrounds to our Board of
Directors. Mr. Schwartz, the third person to join our Board in the
last six weeks, adds an impressive background in investment banking,
specifically in the area of international healthcare. He is an
excellent complement to our newest additions to the Board, John Cook,
Chairman and Chief Executive Officer of The Profit Recovery Group
International, Inc., and Bruce Van Dyne, M.D., a board-certified
neurologist. We feel very fortunate to have experienced corporate
executives and physicians managing our growing, international
healthcare company."
Founded in 1984, CryoLife, Inc. is the leader in the development
and commercialization of living human tissue implantable devices for
use in cardiovascular, vascular and orthopaedic surgeries throughout
the United States and Canada. The Company's BioGlue(R) surgical
adhesive, CE marked in the European Union for use in vascular and
pulmonary sealing and repair, is distributed throughout Europe. The
Company also manufactures CryoLife-O'Brien(R) and CryoLife-Ross(TM)
stentless porcine heart valves which are distributed within the
European Community.
Statements made in this press Release which look forward in time
involve risks and uncertainties and are forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of
1995. Such risks and uncertainties include changes in economic cycles,
competition from other companies, changes in laws and governmental
regulations applicable to the Company and other risk factors detailed
in the Company's Securities and Exchange Commission filings, including
the Company's Form 10-K for the year ended December 31, 1998.
The Company web site is: http://www.cryolife.com
Editor's Note:
CryoLife Customer Service may be accessed by telephone:
800/438-8285 (U.S. and Canada)
770/419-3355 (International)
770/590-3753 (International fax)
E-mail: customerservice@cryolife.com
CONTACT: CryoLife Inc., Atlanta
Roy Vogeltanz, 800/438-8285